BamSEC and AlphaSense Join Forces
Learn More

Guided Therapeutics Inc

OTC: GTHP    
Share price (11/22/24): $0.18    
Market cap (11/22/24): $11.3 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 10-Q 13 pages Common Stock Purchase Warrant Guided Therapeutics, Inc
12/34/56
EX-10.3
from 10-Q 13 pages Common Stock Purchase Warrant Guided Therapeutics, Inc
12/34/56
EX-10.2
from 10-Q 2 pages Promissory Note
12/34/56
EX-10.1
from 10-Q 1 page Promissory Note
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.8
from 10-Q 11 pages The Issue Price of This Note Is $62,100.00 the Original Issue Discount Is $8,100.00
12/34/56
EX-10.7
from 10-Q 12 pages Securities Purchase Agreement
12/34/56
EX-10.6
from 10-Q 1 page Promissory Note
12/34/56
EX-10.5
from 10-Q 17 pages Promissory Note
12/34/56
EX-10.4
from 10-Q 11 pages Promissory Note
12/34/56
EX-10.3
from 10-Q 12 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 12 pages Exchange Agreement Dated April 15, 2024
12/34/56
EX-10.1
from 10-Q 16 pages Promissory Note Dated June 28, 2024
12/34/56
EX-10.3
from 10-Q 1 page Promissory Note
12/34/56
EX-10.2
from 10-Q 1 page Promissory Note
12/34/56
EX-10.1
from 10-Q 5 pages Guided Therapeutics, Inc. (The “Company”) Is Pleased to Offer to You the Opportunity to Exchange All of the Common Stock Purchase Warrants of the Company Issued as Commission Warrants (The “Exchange Warrants”) Currently Held by You (The “Holder”) in Shares of Common Stock. Capitalized Terms Not Otherwise Defined Herein Shall Have the Meanings Set Forth in the Common Stock Purchase Warrant Agreement, Pursuant to the Date of Issuance, Between the Company and the Purchasers Signatory Thereto Pursuant to Which the Company Issued the Exchange Warrants
12/34/56
EX-10.6
from 10-Q 2 pages Amendment #1 to Exchange Agreement
12/34/56
EX-10.4
from 8-K 16 pages Common Stock Purchase Warrant Guided Therapeutics, Inc
12/34/56
EX-10.3
from 8-K 16 pages Common Stock Purchase Warrant Guided Therapeutics, Inc
12/34/56
EX-10.2
from 8-K 14 pages Exchange Agreement
12/34/56